Skip to main content
Innoviva, Inc. (THRX)
Feb 14, 2024 - THRX was delisted (reason: acquired by Concentra Biosciences)
4.060
0.00 (0.00%)
Inactive · Last trade price on Feb 13, 2024

Theseus Pharmaceuticals Revenue

In the year 2024, Theseus Pharmaceuticals had annual revenue of $358.71M with 15.54% growth. Theseus Pharmaceuticals had revenue of $91.81M in the quarter ending December 31, 2024, with 6.95% growth.

Revenue (ttm)
$358.71M
Revenue Growth
+15.54%
P/S Ratio
3.19
Revenue / Employee
$2,824,496
Employees
127
Market Cap
1.14B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024358.71M48.25M15.54%
Dec 31, 2023310.46M-20.88M-6.30%
Dec 31, 2022331.34M-60.53M-15.45%
Dec 31, 2021391.87M55.07M16.35%
Dec 31, 2020336.79M75.78M29.03%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

THRX News

More News